Zoetis Inc. operates as a prominent global animal health enterprise, dedicated to the research, development, production, and marketing of advanced pharmaceuticals, biologicals, and diagnostic solutions. Its extensive product portfolio targets a broad spectrum of animals, encompassing livestock like cattle, pigs, poultry, fish, and sheep, as well as companion animals such as dogs, cats, and horses, serving both the United States and international markets. The company's offerings include a diverse range of vaccines, designed as biological preparations to prevent afflictions of the respiratory, gastrointestinal, and reproductive systems, or to stimulate a targeted immune response.